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Pregnancy-associated glycoproteins (PAGs) are a large grouping of placental proteins that belong to the aspartic peptidase
gene family. Although useful to detect pregnancy in ruminant species, the function of these molecules is unclear. Several PAGs
expressed by trophoblast binucleate cells can enter the maternal circulation, suggesting that they could have a systemic role
in altering maternal physiology. The objective of this work was to examine whether these circulating placental antigens were
important in pregnancy by actively immunizing ewes against them. PAGs were purified by pepstatin-affinity chromatography
and conjugated to the immunogenic protein, keyhole limpet hemocyanin (KLH). Ewes were immunized with PAG–KLH conjugate
(n5 22) or with KLH alone (n5 9), and bred to intact rams. Blood samples, collected on Day 0 (day of estrus), Day 10, Days
15 to 25 and weekly throughout pregnancy, were analyzed for PAG by an ELISA. On Day 30, pregnancy was confirmed by
ultrasound. Ewes immunized against PAG–KLH produced a range of reactive anti-PAG titers, whereas all immunized ewes
had high anti-KLH immunoreactivity. PAGs became detectable in the anti-KLH (control) ewes at Day 21.66 2.2 of pregnancy.
Those ewes immunized against PAGs (n5 7), that had very low immunoreactivity toward PAGs, had measurable PAG by Day
22.96 1.3, and their PAG serum profiles throughout pregnancy did not differ from the controls. Those exhibiting moderate to
high anti-PAG immunoreactivity (n5 15), had significantly lower PAG concentrations than controls, with antigen not becoming
detectable until Day 48.16 15.6. The decrease in circulating PAG in the immunized animals did not correlate with changes in
pregnancy rates, lamb number or lamb birth weight. These results suggest that while PAGs may play a role in maintaining
pregnancy, their major contribution is likely to be at the fetal–maternal interface. Their actions at extra-placental sites are
presumably of more secondary importance.
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Implications
The group of protein known as pregnancy-associated glyco-
proteins, or PAGs, are abundantly produced by the placenta
of many agriculturally important livestock. However, their
role during pregnancy is a mystery. To further understand
these complex proteins, experiments were performed to
‘inactivate’ PAGs in maternal blood by coating them
with antibodies. Interestingly, the ability to coat PAGs
with antibodies was successful, but there was no obvious
negative impact on pregnancy. One interpretation of these
results is that the systemic role of PAGs may be secondary
to their local role at the interface between the placenta and
the maternal uterus.
Introduction
The pregnancy-associated glycoproteins (PAGs) are a large
family of glycoproteins produced by placental trophoblasts of
even-toed ungulates (animals comprising the Artiodactyla
order). In the Ruminantia sub-order, the PAGs are repre-
sented by two distinct groupings comprising ancient and
modern PAGs – based on the relative times at which they
arose during Artiodactyl evolution (Garbayo et al., 2000;
Green et al., 2000; Hughes et al., 2000). The genes for the
former are transcribed in both the trophoblast populations of
the ruminant placenta (the mononucleate and the binucleate
(BNCs) trophoblasts) (Garbayo et al., 2000; Green et al.,
2000). In contrast, the modern PAG genes represent a much
larger group and they are transcribed exclusively by BNCs.
Many BNC products are able to gain access to maternal- E-mail: greenjo@missouri.edu
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tissues (Duello et al., 1986; Liang et al., 1999). Indeed, the
modern/BNC-specific PAGs can be found circulating in
maternal blood soon after apposition and attachment of the
conceptus to the uterine epithelium (Sasser et al., 1986; Zoli
et al., 1992; Green et al., 2005). This feature of the modern/
BNC PAGs has been exploited as the basis for pregnancy
diagnosis in cattle and related ruminants. Not surprisingly,
the modern PAGs have received the bulk of attention from
animal scientists and have been the subject of several
biochemical, molecular and functional studies (Del Vecchio
et al., 1996; Xie et al., 1997; Green et al., 2000; Hughes
et al., 2003; Klisch and Leiser, 2003; Weems et al., 2003;
Wooding et al., 2005; Klisch et al., 2008). However, despite
such efforts, the functional role of the PAGs remains a
mystery. At least a part of the ambiguity arises from the fact
that different research groups have come up with rather
distinct results, even though most of the experiments have
been performed with similar preparations of purified PAG-1
(Pregnancy-specific protein B (PSPB)) – the prototypical
member of the BNC-specific PAGs. Some of the proposed
functions for PAGs are summarized here.
PAGs have been proposed to have both direct and
indirect luteotrophic activity, acting to maintain progester-
one production once the pregnancy has become estab-
lished. When administered to cultured bovine luteal cells,
PAG-1/PSPB promoted release of the luteotrophic com-
pound, prostaglandin E2 (PGE2) (Del Vecchio et al., 1995a
and 1996; Weems et al., 1998a) and an increase in pro-
gesterone (Del Vecchio et al., 1996; Weems et al., 1998b).
However, other studies reported no increase in progester-
one (Del Vecchio et al., 1995a and 1995b). PAG-1 may also
elevate the production of PGE2 by cultured endometrium
from both cattle and sheep (Del Vecchio et al., 1990;
Weems et al., 2003). A working model based on these data
visualizes PAG-1/PSPB being up-regulated by placental
estrogen; PAG-1 then increases the production of PGE2,
which is believed to augment the synthesis of progesterone
(Weems et al., 1999, 2001 and 2002).
Another role has been proposed in which the PAGs act in
an immunomodulatory capacity. In cattle, the phagocytotic
and oxidative burst activities of circulating polymorphonuclear
neutrophil leukocytes are lowest around the time of parturi-
tion and in the first 3 weeks after calving (Kehrli et al., 1989;
Saad et al., 1989). Dosogne et al. (1999) and Hoeben et al.
(2000), both noted that bovine PAG concentrations peak
immediately prior to this decline in leukocyte activity. They
hypothesized that there could be an association between the
high PAG concentrations at parturition and lowered leukocyte
killer activities. There are, in fact, some indications that PAG-1
(PSPB) can be immunosuppressive (Hoeben et al., 1999). For
example, bovine PAG-1 can reduce the proliferative activity
of bovine hematopoietic cells in vitro (Hoeben et al., 1999).
The PAGs can also associate with uterine serpins – proteins
able to inhibit natural killer cell activity and the proliferation
of peripheral blood lymphocytes in vitro (Mathialagan and
Hansen, 1996; Peltier et al., 2000). Finally, PAG-1 (PSPB) has
been shown to induce the release of the alpha chemokine,
granulocyte chemotactic protein-2, from cultured bovine
endometrial explants and an endometrial cell line (BEND cells)
(Austin et al., 1999).
Clearly, the role of PAGs is uncertain and complicated by
the fact that there are so many of them (Garbayo et al., 2000;
Green et al., 2000; Brandt et al., 2007). A further difficulty in
understanding how they operate arises from the fact that
nearly all earlier functional studies have been performed
in vitro rather than on intact animals. In this report, we
attempted to gain some preliminary insight into PAG function
by auto-immunizing ewes against a mixture of purified native
ovine PAGs. The underlying assumption was that either
eliminating or suppressing the ability of PAG to act outside
the placenta would either compromise the pregnancy as it
proceeded, or not allow it to become established in the first
place. Similar autoimmune approaches have been used by
others to study potential contraceptive vaccines in humans
(Stevens, 1979; Talwar et al., 1994), and to test the functions
of specific circulating hormones and placental proteins in
other species (Medan et al., 2004).
Methods
Preparation of proteins for immunizations
A preparation consisting of a mixture of ovine PAG was
obtained essentially as described earlier for the isolation of
bovine PAG (Green et al., 2005; Wooding et al., 2005;
Green and Roberts, 2006). Briefly, ovine cotyledons were
collected from late stage pregnant ewes (,Day 100;
n5 3) by manual separation of the placentomes into
cotyledon and caruncular components. Developmental
stage was estimated by measurement of crown–rump
lengths (Hammond, 1927; Noakes et al., 2001). The isolated
cotyledons were homogenized in 20 mM Tris (pH 8.0),
50 mM NaCl, 2 mM ethylenediamine tetraacetic acid
(EDTA), 0.2 mM phenylmethylsulfonylfluoride (PMSF),
0.02% (w/v) NaN3. Insoluble material was removed by
centrifugation at 50003 g for 30 min. The cleared super-
natant was placed in 50 000 MWCO dialysis tubing and
dialyzed against .100 volumes of 20 mM Tris (pH 7.0),
150 mM NaCl, 1 mM EDTA, 0.02% (w/v) sodium azide,
20 mM PMSF, 1 mM 2-mercaptoethanol. The presence of
immunoreactive PAG was confirmed by immunoblotting
with a rabbit anti-ovine PAG-1 antiserum (#80) raised
against recombinant ovine PAG-1 that had been produced
in bacteria (Wooding et al., 2005). Since PAGs belong to the
aspartic peptidase family of enzymes, the aspartic peptidase
inhibitor, pepstatin, was used to selectively bind PAGs
present in cotyledons. The cleared cotyledonary extract was
applied to a column containing 50 ml of beaded pepstatin-A
agarose (4% cross-linked; Sigma, St Louis, MO, USA)
equilibrated in the same buffer. After loading, the matrix
was washed with 40 column volumes of the loading buffer,
followed by 10 column volumes of 20 mM Tris (pH 7.0), 1 M
NaCl, 1% Triton X-100, 1 mM EDTA, 0.02% (w/v) sodium
azide, 20 mM PMSF, 1 mM 2-mercaptoethanol. Proteins
remaining bound to the column, were eluted by increasing
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the pH of the buffer in a stepwise fashion (pH 8.0, 9.5 and
10.5). Elution fractions were collected and analyzed by dot
blot for the presence of PAG immunoreactivity. The fractions
that contained PAG were pooled and their protein con-
centrations were determined by Bradford assay (Bradford,
1976).
The material that flowed-through from the pH 7 pepstatin
column was dialyzed, as described above, against 20 mM
sodium citrate (pH 5.0), 150 mM NaCl, 1 mM EDTA, 0.02%
(w/v) sodium azide, 20 mM PMSF, 1 mM 2-mercaptoethanol.
After centrifugation, the supernatant was applied to the
pepstatin column equilibrated in the same pH 5.0 buffer. The
column was washed (40 column volumes of loading buffer
followed by 10 column volumes of 20 mM sodium citrate (pH
5.0), 1 M NaCl, 1% Triton X-100, 1 mM EDTA, 0.02% (w/v)
sodium azide, 20 mM PMSF, 1 mM 2-mercaptoethanol).
Bound PAGs were eluted and analyzed for the presence of
PAG. Since both the neutral and acidic-binding preparations
had similar purity and immunoreactivity, aliquots from each
were pooled for immunizing ewes.
To gain some insight into which PAGs were represented in
the preparations, the eluted proteins were subjected to SDS-
PAGE and the main immunoreactive bands were subjected
to reduction, alkylation of cysteines with iodoacetamide
and digested with trypsin for 16 h (Shevchenko et al., 1996;
Belghazi et al., 2001). The positive ion mass spectra of the
resulting peptides were obtained in the presence of alpha-
cyano-4-hydroxycinnamic acid matrix. The most abundant
ions were further subjected to sequencing by MS/MS (tandem
mass spectrometry). The ion spectra were obtained on a 4700
MALDI TOF/TOF mass spectrometer (Applied Biosystems,
Foster City, CA, USA) (Shevchenko et al., 1997; Link et al.,
1999; Baldwin et al., 2001; Belghazi et al., 2001). The
monoisotopic masses of the acquired spectra were used for
searching against a nonredundant translated mammalian
sequence database (NCBInr) by using the Mascot (www.
matrixscience.com) or Protein Prospector MS FIT programs
(http://prospector.ucsf.edu/) (Clauser et al., 1999; Perkins
et al., 1999). No significant matches were obtained with
just the peptide mass fingerprint data, so searches were
repeated with both the MS and MS/MS spectra. The predicted
peptide sequences matched several known ovine, bovine and
caprine PAGs.
Immunization of sheep
PAGs in the eluted fractions were dialyzed against .1000
volumes of 10 mM sodium phosphate (pH 7.0), 150 mM NaCl
and cross-linked to keyhole limpet hemocyanin (KLH) by using
glutaraldehyde (Harlow and Lane, 1988). The PAG was inclu-
ded at a 30-fold molar excess relative to the amount of KLH
and the final glutaraldehyde concentration was at a 20-fold
molar excess relative to the PAG. Cross-linking was allowed to
proceed overnight at room temperature and the reaction was
terminated by adding glycine (pH 7.2) to a final concentration
of 20 mM (Harlow and Lane, 1988).
The animals used in this study were mostly Romanov-
crossbred ewes that were maintained at the University of
Missouri Sheep Farm. The ewes were immunized sub-
cutaneously with either 100mg of KLH (n5 9 animals) or
300mg of ovine PAG, in the form of a PAG–KLH conjugate
(n5 22 animals). The protein solutions were emulsified
with an equal volume of Freund’s complete adjuvant
(Sigma) immediately prior to the injections. Subsequent
‘booster’ injections were performed with Freund’s incom-
plete adjuvant. The animals were re-exposed to the
immunogens at approximately 8-week intervals for a total
of five immunizations. The final injection was administered
2 weeks prior to breeding.
The ewes were synchronized for estrus by two intra-
muscular injections of a prostaglandin analog (Lutalyse;
Pharmacia & Upjohn Co., Kalamazoo, MI, USA) adminis-
tered 9 days apart. The ewes were bred to two rams of
proven fertility. Four animals that cycled back on Day 16
after breeding were re-bred to the same rams and their
samples and lambing data were also included in the study.
Blood samples for serum were collected from the jugular
vein, from each animal, at the time of standing heat (Day 0)
and on Days 10, 14 to 28 and then weekly, throughout the
remainder of pregnancy. The number and weight of the
lambs born to each ewe were collected within 3 h of birth.
The procedures used in this study were carried out under
protocols approved by the University of Missouri Animal
Care and Use Committee.
PAG ELISA
To determine if PAG autoimmunization had any influence on
circulating PAG concentrations during pregnancy, an ovine
PAG ELISA was established by using methods that have been
described earlier, in detail, for bovine PAGs (Green et al.,
2005; Green and Roberts, 2006). Briefly, ovine PAGs were
purified by pepstatin-affinity chromatography, as described
above, and used for the production of polyclonal antibodies in
rabbits and as a standard in the ELISA (Green et al., 2005;
Green and Roberts, 2006). The resulting antibodies were
purified by using protein A-Sepharose (Pierce Biotechnology
Inc., Rockford, IL, USA) and the immunoglobulin was quan-
tified by Bradford assay with rabbit IgG (Sigma) as the
standard (Bradford, 1976; Harlow and Lane, 1988).
The ELISA was an indirect ‘sandwich’ design. Purified rabbit
anti-ovine-PAG antibodies (4mg) were coated in each well
of a 96-well ELISA plate. The wells were blocked in 2% BSA
and 1% non-fat dry milk. Serially diluted ovine-PAG standard
(diluents: non-pregnant ewe serum) or unknown serum
samples were added to the wells and the plate was incubated
at 48C overnight. Unbound protein was removed by washing
in a 96-well plate washer (BioTek, Winooski, VT, USA) and the
wells were then incubated with 3mg of biotinylated rabbit
anti-PAG IgG for 30 min at room temperature. The plate was
washed again and neutravidin–AP (alkaline phosphatase)
conjugate (Pierce Biotechnology) was added and allowed to
incubate at room temperature for 30 min. After washing,
0.1 ml of 1 mg/ml p-nitrophenyl phosphate (PNPP) (Sigma)
was added to each well. After 15 to 30 min, the absorbance
at 405 nm was measured by using an EL808 plate reader
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(BioTek). A PAG standard dilution series was included on
every ELISA plate.
Assay validation
Two serum samples representing distinct PAG concentrations
were assayed seven times in quadruplicate to calculate intra-
and inter-assay variation. Parallelism was assessed by serially
diluting late pregnant ewe sera, and measuring PAG reactivity
in the sera relative to the PAG standards.
Data analysis
Standard curves were generated by using purified native
ovine PAG isolated by pepstatin-affinity chromatography.
The PAG standards were adjusted to provide a range from
0.039 to 40 ng. A standard curve was included on every
ELISA plate and was generated by non-linear regression of
a LOG (ng PAG std) v. absorbance plot, using the Graphpad
Prism software (version 3.02 for Windows; San Diego, CA,
USA; www.graphpad.com).
Differences in lamb number and weights, as well as mean
PAG concentrations between groups were tested by
ANOVA, using the data processing functions of the
GraphPad Prism Software.
Measurement of anti-PAG titers present in the
immunized ewes
To determine the extent to which the immunized animals
developed antibodies to the immunogens, 1mg of KLH or
purified PAGs was coated on 96-well ELISA plates. The
plates were blocked as described above and serial dilutions
of sera from each ewe were incubated in the wells over-
night. The plates were washed and incubated with anti-
sheep–AP conjugate (Jackson ImmunoResearch, West
Grove, PA, USA) and hydrolysis of PNPP was measured at
405 nm (Green and Roberts, 2006). The respective titers
representing ewe sera reactivity toward the plated immu-
nogens were calculated.
Results
The aspartic peptidase inhibitor, pepstatin A, was used to
affinity purify PAGs from D100 cotyledonary extracts
(Stewart et al., 1994; Wright et al., 1997; Green and
Roberts, 2006). The isolated PAGs were represented in two
major bands (relative Mr varied from approximately 50 000
to 65 000) when analyzed by one-dimensional SDS-PAGE
(Figure 1). Some differences in electrophoretic mobility
were observed based on the binding conditions (i.e. pH)
employed during PAG isolation (Figure 1a). It was notable
that when only a single binding condition was used (pH
5.0), both main PAG protein bands were represented in the
isolated material (Figure 1b). Despite such mobility differ-
ences, however, there was considerable overlap in the PAGs
represented in the bands. Tryptic digests and peptide
sequencing of the most abundant peaks revealed several
sequences from the major PAG bands that most closely
matched ovine PAG-5 (AAB53226) and PAG-6 (AAB53227),
with additional matches with ovine PAG-8 (AAB53229)
and weaker matches with other bovine and caprine PAGs
(Table 1). The preparations shown in Figure 1a were part of
those used to immune the ewes. The material shown in
Figure 1b was used for antibody production in rabbits and
as a native PAG standard in the ELISA. The generated
antiserum reacted with all the original components in the
antigen preparation (Figure 1b).
In order to assess the effectiveness of the auto-
immunization protocol, it was necessary to have an assay
capable of quantifying PAGs in pregnant ewes. Therefore,
part of this work involved the establishment of an ELISA for
the detection of circulating ovine PAGs. The assay could
efficiently detect PAG standard diluted in non-pregnant ewe
serum, down to 1 ng/ml. A plot of serial dilutions of the
PAG standard revealed a sigmoidal-type curve typical of
most antibody–antigen interactions (Figure 2). Parallelism
between PAGs present in pregnant ewe sera and the pur-
ified PAG standard, indicated that the PAG detected in
maternal sera is very similar to that used as standard
(Figure 2). The intra- and inter-assay repeatability of the
ELISA, used to measure PAG concentrations in pregnant
ovine serum, was determined from ewes representing dis-
tinct concentrations of PAG. The intra-assay CV averaged
8.8% and the inter-assay CV averaged 13.5%.
Active immunization of ewes against PAGs produced a
range of immune responses in the animals. Of the 22 ani-
mals that were auto-immunized before breeding, seven
developed no or little reactivity toward PAGs while 15
produced high titers toward native PAGs. Those seven
animals that did not respond to the immunization either did
not react at all or the reactivity was indistinguishable from
background upon dilution of the sera 1 : 2000. Those ani-
mals that did produce auto-antibodies to native PAGs
exhibited robust reactivity even at a dilution of .1 : 16 000.
Figure 1 Rapid isolation of native pregnancy-associated glycoprotein
(PAG) by pepstatin affinity chromatography: (a) ovine PAG isolated by
binding to pepstatin at pH 7 and 5 (labels are shown below the lanes) and
used for immunization of ewes. (b) Results from a pepstatin–agarose
batch purification of ovine PAGs at pH 5 for use in anti-PAG antibody
production in rabbits and as PAG standard in the ELISA. The panel on the
left is a stained gel showing the isolated proteins. The middle and right
panels are western blots performed on duplicate gels with antibodies
raised against recombinant ovine PAG-1 and the mixture of native ovine-
PAGs, respectively. Normal rabbit serum did not produce any staining
(data not shown).
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All of the immunized animals (PAG–KLH and KLH alone)
exhibited strong reactivity toward KLH in the standard
ELISA. The KLH-immunized animals exhibited no reactivity
toward PAGs in the titering ELISA.
Figure 3a shows the profiles of PAG concentrations in the
serum of the 29 pregnant ewes collected at Day 0, 10 and
13 to 26 after breeding. Weekly sampling throughout
pregnancy is shown in Figure 3b. PAG immunoreactivity in
the KLH-immunized (control) animals rose rapidly between
Days 20 and 26, reaching an average concentration of
40.4 ng/ml by Day 26 (Figure 3a). When viewed over the
course of the entire pregnancy, the PAG profile was biphasic
– with one peak at week 9 (185 ng/ml) and the other peak
at term (175 ng/ml) (Figure 3b).
The concentrations between the low-titer anti-PAG animals
and the KLH controls did differ significantly early in preg-
nancy. However, the PAG profiles eventually came to mirror
one another by the 4th week of pregnancy (Figure 3). For
those animals in the high-titer anti-PAG group, the average
concentration of circulating PAGs deviated from the control
KLH group by Day 24 post-breeding and, remained much
lower than the KLH and low-titer animals throughout the
remainder of the pregnancy (Figure 3b). The maximum
PAG concentration measured in the high-titer animals was
41 ng/ml during the final week of pregnancy (Figure 3b).
The average time at which circulating PAGs exceeded
1 ng/ml was another method used to make comparisons
between groups. PAGs were detectable in the anti-KLH and
anti-PAG (low-titer) animals by Days 21.66 2.2 and
22.96 1.3, respectively. The high-titer animals differed
from the other groups; in these animals, circulating PAGs
did not become detectable until Day 48.16 15.6 (Figure 4)
– well after the time in which a mature placenta has
become established in these animals.
The overall pregnancy rates for the ewes in this study
were well above 90%. Only two of the animals failed to
Table 1 Selected ovine pregnancy-associated glycoproteins (PAG) tryptic peptide sequences obtained by MS/MS (tandem mass spectroscopy)
MH1 matched Submitted peptide NCBI match Sequence matched Peptide location in protein
771.4646 IEGVVVR oPAG8 (2055443) Same 137–143
1032.5216 VYFSVFDR Several PAGs Same 362–369
1046.5312 LYFSVFDR oPAG6 (2055438) and several others Same 362–369
1072.5454 TFSLTYGQR oPAG6 (2055438) TFSITYGCG 127–138
1182.6987 GELNWIPLIK oPAG5 (2055436) GELNWIPLIR 231–240
1256.5972 NWLVHMDR oPAG6 (2055439) NWMVHMDR 244–251
1348.7503 ETWILGDVFLR oPAG5 (2055436) ETWVLGDIFLR 350–360
1389.6748 EGSVVMFGGVDHR oPAG6 (2055438) and several others Same 216–228
1756.9222 EGAVSEPVFAFYLSK oPAG1 (M73961) NEGAFSEPVFAFYLNK 199–214
2280.2067 GELNWVPVIQAGAWSVH(Mox)NR Caprine PAG5 (6179995) Same 232–251
Figure 2 On the left are typical standard curves for purified ovine
pregnancy-associated glycoprotein (PAG) in the ELISA. Serially diluted
PAG standard was incubated overnight at 4 to 88C, to allow
antibody–antigens interactions to achieve equilibrium. A dilution series
of pregnant ewe sera, to assess parallelism in the ELISA between purified
PAGs and those in circulation, is illustrated on the right.
Figure 3 Group comparisons – profiles of pregnancy-associated glycopro-
tein (PAG) concentrations in pregnant ewe serum: (a) PAG concentrations in
ewe sera on Days 0, 10 and 13 to 26 after breeding. The PAG concentration
of the anti-PAG (low) animals differed from the keyhole limpet hemocyanin
(KLH) animals only at Day 25 (P, 0.01). The concentration in the anti-PAG
animals differed from the KLH animals at Day 24 (P, 0.01) and Days
25 and 26 (P, 0.001). (b) PAG concentrations from ewe sera collected at
weekly intervals throughout pregnancy. The PAG concentration in the anti-
PAG animals significantly differed from both the KLH and ‘low’ anti-PAG
animals by the 4th week and remained lower throughout pregnancy. Each
data point represents the mean PAG concentration for each group6 s.e.
*P, 0.01; **P, 0.001.
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become pregnant or take a pregnancy to term (Table 2).
Despite that approximately 23 of the PAG-immunized animals
developed high titers to the antigens, this had no effect
upon pregnancy rates, the number of lambs born per ewe,
or in the birth weight of the lambs (Table 2). There was no
difference in the average length of gestation between the
groups (data not shown).
Discussion
The PAG-1 protein has been implicated as both a luteo-
trophin and as an immunomodulator during pregnancy in
ruminants (Del Vecchio et al., 1995a; Weems et al., 1998b;
Hoeben et al., 2000). It remains unknown if these disparate
functional roles are due to the ability of PAG-1 to act in
many ways (i.e., it is a multi-functional protein) or, if the
protein preparations used in those studies consisted of
multiple PAGs, each with distinct functions. Most of the
studies describing PAG action have been completed in vitro,
and the relevance of such studies to animal physiology, as a
whole, is a legitimate question. With these issues in mind,
the goal of this work was relatively simple and straight-
forward: to determine if circulating PAGs are critical for
maintaining pregnancy in ewes. These experiments
employed autoimmunization of ewes to suppress PAGs
immunologically as a way to gain some insight into PAG
function. The hypothesis being tested was that, if PAGs
circulating in maternal blood were playing a major role
during pregnancy, then a decrease in PAG concentrations
would be reflected in increased pregnancy losses or in the
birth of compromised offspring.
In the control ewes immunized against KLH, the biphasic
serum profiles of PAGs were quite similar to those obtained
by other laboratories (Ruder et al., 1988; Ranilla et al.,
1994). The PAG-immunized animals that failed to develop
strong reactivity toward PAGs (the ‘low-titer’ group)
exhibited profiles that were essentially identical to the KLH-
immunized animals. In contrast, the ability to detect circu-
lating PAGs in the high-titer ewes was delayed and the
concentration of PAGs in pregnant sera was markedly
decreased (Figures 3 and 4). However, despite that
approximately two-thirds of the immunized animals devel-
oped good reactivity toward PAGs, no significant effect was
observed in the subsequent pregnancy (Table 2).
The inability to detect PAGs in sera from immunized
animals presumably was due either to auto-antibodies
interfering with the ability of the anti-PAG antibodies in the
ELISA to bind to PAGs in sera, or to the selective removal
of PAGs from the maternal circulation via clearance
mechanisms (Simister et al., 1997; Vaughn and Bjorkman,
1998; Gorgani and Theofilopoulos, 2007). At present, it is
not possible to determine which mechanism was most
responsible for the decrease in circulating PAG concentra-
tions. However, one might predict that the rabbit anti-PAG
antibodies employed in the ELISA probably had a greater
affinity for PAGs than would the auto-anti-PAG immu-
noglobulins. The rabbit antibodies would have likely dis-
placed the auto-antibodies during the overnight incubation
of the sera in the ELISA plates. Obviously such points are
merely conjecture, however. But regardless of the
mechanism, it is likely that either the coating of circulating
PAGs with auto-antibodies, or the selective removal of
antibody–PAG complexes, would be predicted to interfere
with PAG function in the maternal system. Clearly, the
decrease in circulating PAGs did not disrupt pregnancy –
suggesting that circulating PAGs are present in amounts
much higher than are required for normal function, or that a
Figure 4 Group comparisons – the average day of pregnancy when the
concentration of pregnancy-associated glycoprotein (PAG) in maternal
sera exceeded 1 ng/ml. There was no difference between the ewes
immunized with keyhole limpet hemocyanin (KLH) and those anti-PAG
animals that failed to react strongly with PAG. The PAG in maternal sera
of immunoreactive anti-PAG animals did not become detectable until Day
48. Each bar represents the mean6 s.d. ***P, 0.001.
Table 2 Pregnancy rates, average lambing rate and average lamb birth-weights between the immunization groups
Immunization
group
Pregnancy
ratec
Lambs
per ewec
Average lamb birth
weight per ewe (kg)c
Average lamb birth
weight per group (kg)c
KLH 9/9 2.46 0.53 3.046 0.63 3.046 0.77
PAG
Low reactivitya 7/7 2.36 0.76 3.186 0.73 3.096 0.82
High reactivityb 13/15 2.46 0.87 3.276 1.14 3.006 1.15
KLH5 keyhole limpet hemocyanin; PAG5 pregnancy-associated glycoproteins.
aAnimals were placed into the low-reactive group if they failed to recognize PAGs in a direct ELISA or if the reactivity was lost upon dilution .1 : 2000.
bAnimals were placed into the high-reactive group if they could recognize PAGs in a direct ELISA at a dilution >1 : 16 000.
cThere were no statistically significant differences between the values in each column.
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systemic role of circulating PAGs may not be absolutely
required for the maintenance of pregnancy.
On the other hand, paracrine-like activities of the PAGs
might well remain operational in such PAG-immunized
ewes. There was no way to measure the amount of
immunoreactive PAGs present at extra-vascular sites near
or at the maternal–placental interface, where a substantial
amount of PAG immunoreactivity is known to accumulate
(Wooding et al., 2005). What was clear was that cell-based
immune-directed attack on the fetal placenta, whether
through complement or activated T-cells, was clearly not
pervasive in these animals since no signs of increased
pregnancy failure, late term miscarriage, or birth of small
lambs were observed. Therefore, it appears that local
actions of the PAGs remained relatively unaffected,
although further studies are needed to test this contention.
In summary, this work sought to study the function of PAGs
in pregnant animals by the immunological removal or
blocking of circulating PAGs in pregnant ewes. The major
outcome from these studies was that auto-immunization of
ewes against PAGs was successful in decreasing circulating
PAGs, but did not produce an obvious impact on the preg-
nancy. Although these results do not exclude a systemic role
for the PAGs, one can extrapolate from these data that future
work on PAG function might, more productively, be focused
on events taking place in the microenvironment at the
placenta–uterine interface.
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